Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
PUT
Wendy's
WEN
$1.4B
| $1.31M | ﹤0.01% |
+75,000
| New | +$1.28M |
|
3102
PUT
AST SpaceMobile
ASTS
$17.6B
| $1.31M | ﹤0.01% |
+50,000
| New | +$1.13M |
|
3103
Bristow Group
VTOL
$1.34B
| $1.31M | ﹤0.01% |
37,691
+27,953
| +287% | +$1.01M |
|
3104
Wave Life Sciences
WVE
$1.09B
| $1.31M | ﹤0.01% |
159,241
+100,498
| +171% | +$601K |
|
3105
AdvanSix
ASIX
$541M
| $1.3M | ﹤0.01% |
42,952
+32,706
| +319% | +$891K |
|
3106
Carter's
CRI
$1.42B
| $1.3M | ﹤0.01% |
20,077
+7,429
| +59% | +$477K |
|
3107
CALL
Fortrea Holdings
FTRE
$1.82B
| $1.3M | ﹤0.01% |
65,200
+5,200
| +9% | +$122K |
|
|
NVMI
3108
Nova
NVMI
$12.4B
| $1.3M | ﹤0.01% |
6,259
+5,199
| +490% | +$1.11M |
|
3109
Health Catalyst
HCAT
$154M
| $1.3M | ﹤0.01% |
160,151
+56,369
| +54% | +$407K |
|
3110
Astec Industries
ASTE
$1.16B
| $1.29M | ﹤0.01% |
40,529
+22,017
| +119% | +$707K |
|
3111
Archer Aviation
ACHR
$3.54B
| $1.29M | ﹤0.01% |
427,023
+312,440
| +273% | +$1.19M |
|
3112
Playtika
PLTK
$1.52B
| $1.29M | ﹤0.01% |
163,138
+7,480
| +5% | +$56.2K |
|
3113
PUT
Viking Therapeutics
VKTX
$3.7B
| $1.29M | ﹤0.01% |
+20,400
| New | +$1.2M |
|
|
CFLT
3114
PUT
DELISTED
Confluent
CFLT
| $1.29M | ﹤0.01% |
+63,300
| New | +$1.42M |
|
3115
QuidelOrtho
QDEL
$1.14B
| $1.29M | ﹤0.01% |
28,257
-41,945
| -60% | -$1.7M |
|
3116
GCM Grosvenor
GCMG
$754M
| $1.29M | ﹤0.01% |
113,823
+41,259
| +57% | +$444K |
|
3117
Humacyte
HUMA
$176M
| $1.29M | ﹤0.01% |
236,742
+151,458
| +178% | +$999K |
|
3118
The RMR Group
RMR
$325M
| $1.29M | ﹤0.01% |
50,674
+18,100
| +56% | +$447K |
|
3119
ATN International
ATNI
$366M
| $1.28M | ﹤0.01% |
39,717
+15,390
| +63% | +$405K |
|
3120
Hayward Holdings
HAYW
$3.21B
| $1.28M | ﹤0.01% |
83,628
-51,157
| -38% | -$708K |
|
3121
Pan American Silver
PAAS
$18.2B
| $1.28M | ﹤0.01% |
61,439
+37,480
| +156% | +$790K |
|
3122
First Community Bankshares
FCBC
$900M
| $1.28M | ﹤0.01% |
29,709
+20,412
| +220% | +$852K |
|
|
PRA
3123
DELISTED
ProAssurance
PRA
| $1.28M | ﹤0.01% |
85,117
+64,228
| +307% | +$819K |
|
3124
Limbach Holdings
LMB
$855M
| $1.28M | ﹤0.01% |
16,879
+13,402
| +385% | +$852K |
|
|
SVC
3125
Service Properties Trust
SVC
$1.04B
| $1.28M | ﹤0.01% |
56,084
+42,426
| +311% | +$1.06M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.